Delivery Order SPE2DX22D0010-SPE2D825FJP41
- Not listed
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Concerta ER Tablets 36mg, with a ceiling value of $1,849.39. This firm fixed-price, non-set-aside contract was awarded on June 6, 2025, with an ultimate completion date of June 9, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order serves as a child contract under the company's existing...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency valued at $6,600.47 for Concerta ER 18 mg tablets (100-count packages). This competitive, firm fixed-price contract was awarded on June 18, 2025, with an ultimate completion date of June 20, 2025. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $9,289.80 by the Defense Logistics Agency (DLA) on July 18, 2025, for the supply of Concerta ER 36 mg tablets (100-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 21, 2025. The place of performance is listed as Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Concerta ER 54 mg tablets (100-count units) valued at $1,199.34, with a firm fixed price arrangement. The contract was awarded on September 10, 2025, with an ultimate completion date of September 11, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $15,296.82 to AmerisourceBergen Drug Corp for the supply of Concerta ER 36 mg tablets (100-count units). This non-competitive, firm fixed-price delivery order was issued on August 12, 2025, with an ultimate completion date of August 13, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform fulfillment from its corporate office location. This award represents a child contract under the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Concerta ER 36 mg tablets (100-count units) with a ceiling value of $5,573.88. This is a firm fixed price delivery order with no set-aside designation, issued under competitive procedures. The contract will be performed in Conshohocken, Pennsylvania, with an ultimate completion date of July 22, 2025. This delivery order is issued as a child contract under AmerisourceBergen's...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Concerta ER Tabs 36mg, a controlled-release methylphenidate medication used in the treatment of attention deficit hyperactivity disorder. This firm fixed-price delivery order, valued at $33,063.14, represents a non-set-aside competitive award and is scheduled for ultimate completion by August 8, 2025. The contract will be performed at...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $19,079.33 by the Defense Logistics Agency (DLA) for the supply of Concerta ER 27 mg tablets (100-count units). This competitively awarded, firm fixed-price contract is non-set-aside and was issued on August 7, 2025, with an ultimate completion date of August 8, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen's corporate office is headquartered. This delivery order...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a firm fixed-price delivery order valued at $18,949.34 on August 12, 2025, for the supply of Concerta ER Tabs 36mg. The contract, which is set to be completed by August 13, 2025, is funded by the Medical Supply Chain, a defense-focused federal agency supporting military and veteran healthcare systems. This delivery order is a child contract issued under AmerisourceBergen's...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a firm fixed-price delivery order valued at $41,982.42 on September 9, 2025, for the supply of Concerta ER Tabs 27mg. The contract, which is not set-aside and was competitively awarded, is scheduled for completion by September 10, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is funded through the...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D825FJP41Delivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $57,644.29 for Concerta ER Tablets 27mg under a Defense Logistics Agency (DLA) Medical Supply Chain contract. This competitively awarded, firm fixed-price delivery order was executed on September 23, 2025, with an ultimate completion date of September 24, 2025. The contract carries no set-aside designation and represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is listed as Conshohocken, Pennsylvania. This delivery order supports the federal government's pharmaceutical procurement needs for military and veteran healthcare systems. Concerta ER (extended-release methylphenidate) is a central nervous system stimulant used in the treatment of attention deficit hyperactivity disorder, a critical medication within the Defense Health Agency's formulary. AmerisourceBergen's role as a pharmaceutical prime vendor enables the company to supply a comprehensive range of medications and medical supplies to support military healthcare programs globally, making this delivery order part of the broader strategic approach to ensure reliable pharmaceutical access across defense medical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $57.6k | 9/23/25 |